Enhancing co-stimulation of CAR T cells to improve treatment outcomes in solid cancers
Immunotherapy Advances · 01.01.2021 · 1 (1)
DOI: 10.1093/immadv/ltab016 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Immunotherapy Advances, online erschienen am 31.07.2021. Verfasst von Aaron J Harrison und 4 weiteren Autor:innen. Beteiligte Einrichtung: Cancer Immunology Program, Peter MacCallum Cancer Center, Melbourne, Victoria, Australia. Die Arbeit wurde bisher 23-mal zitiert (Crossref) und nennt 75 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: National Health and Medical Research Council of Australia, National Breast Cancer Foundation of Australia.
Abstract (Originalsprache)
Co-stimulation is a fundamental component of T cell biology and plays a key role in determining the quality of T cell proliferation, differentiation, and memory formation. T cell-based immunotherapies, such as chimeric antigen receptor (CAR) T cell immunotherapy, are no exception. Solid tumours have largely been refractory to CAR T cell therapy owing to an immunosuppressive microenvironment which limits CAR T cell persistence and effector function. In order to eradicate solid cancers, increasingly sophisticated strategies are being developed to deliver these vital co-stimulatory signals to CAR T cells, often specifically within the tumour microenvironment. These include designing novel co-stimulatory domains within the CAR or other synthetic receptors, arming CAR T cells with cytokines or using CAR T cells in combination with agonist antibodies. This review discusses the evolving role of co-stimulation in CAR T cell therapies and the strategies employed to target co-stimulatory pathways in CAR T cells, with a view to improve responses in solid tumours.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Cancer Immunology Program, Peter MacCallum Cancer Center, Melbourne, Victoria, Australia.
- Sir Peter MacCallum Department of Oncology, University of Melbourne, Parkville, Victoria, Australia.
ORCID-Profile: Aaron J Harrison
Förderung
- National Health and Medical Research Council of Australia
- National Breast Cancer Foundation of Australia
Zitieren
APA
Harrison, A. J., Du, X., von Scheidt, B., Kershaw, M. H., & Slaney, C. Y. (2021). Enhancing co-stimulation of CAR T cells to improve treatment outcomes in solid cancers. Immunotherapy Advances, 1(1). https://doi.org/10.1093/immadv/ltab016
Vancouver
Harrison AJ, Du X, von Scheidt B, Kershaw MH, Slaney CY. Enhancing co-stimulation of CAR T cells to improve treatment outcomes in solid cancers. Immunotherapy Advances. 2021;1(1). doi:10.1093/immadv/ltab016
BibTeX
@article{Harrison2021,
author = {Harrison, Aaron J and Du, Xin and von Scheidt, Bianca and Kershaw, Michael H and Slaney, Clare Y},
title = {Enhancing co-stimulation of CAR T cells to improve treatment outcomes in solid cancers},
journal = {Immunotherapy Advances},
year = {2021},
volume = {1},
number = {1},
doi = {10.1093/immadv/ltab016}
}
EUVIMED